Analysts set price targets for Syndax Pharmaceuticals stock on September 1, 2025.
3 reports, 3 independent
Updated Oct 15
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts set price targets for Syndax Pharmaceuticals stock on September 1, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BoA assesses that the selloff in Syndax Pharmaceuticals stock is overdone.1 source
Analysts set price targets for Syndax Pharmaceuticals stock.1 source
Keep exploring
The entities involved
-
Syndax Pharmaceuticals
business
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- tickerreport.com
- ZacksWall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade Syndax Pharmaceuticals (SNDX) closed the last trading session at $16.33, gaining 63.6% over the past four weeks,
- TipRanksCiti ups Syndax target, opens ‘upside catalyst watch’ Citi analyst Yigal Nochomovitz raised the firm’s price target on Syndax (SNDX) to $51 from $46 and keeps a Buy rating on the shares. The firm als